Loewen Andrea's Form 4 filing
Reata Pharmaceuticals Inc (RETA) · filed Mar 9, 2023
- Accession no.
- 0001209191-23-017553
- Filed
- Mar 9, 2023
- Trade date
- Mar 7, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.59M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Loewen AndreaCIK 0001591100 | Officer (SVP, Global Regulatory Affairs) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2023 | Class A common stock | MOption exerciseAcquired | +15,000 | $27.32 | +$409,800 | 57,793 | Direct | |
| Mar 7, 2023 | Class A common stock | SSaleDisposed | −17,836 | $83.36 | −$1,486,808.96 | 39,957 | Direct | |
| Mar 7, 2023 | Class A common stock | SSaleDisposed | −1,200 | $84.44 | −$101,328 | 38,757 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2023 | Class A common stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 35,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.